Genzyme Recalls Nine Lots of Kidney Transplant Drug on Stability Concerns

Drug Industry Daily
A A
Genzyme is voluntarily recalling nine lots of its kidney transplant drug Thymoglobulin after one product lot failed a periodic stability test, the Sanofi subsidiary says.

To View This Article:

Login

Subscribe To Drug Industry Daily